Hikma Pharmaceuticals Reports - Industry Research
Reports Featuring Hikma Pharmaceuticals
Global Opioids Market
The Global Opioids Market size is estimated at USD 23.94 billion in 2024, and is expected to reach USD 28.78 billion by 2029, growing at a CAGR of 3.75% during the forecast period (2024-2029).
Capecitabine Market
The Capecitabine market studied was anticipated to grow with a CAGR of 5.5% during the forecast period owing to the rising demand for target drug therapy to decrease the possible side effects without affecting normal cells.
Global Specialty Injectable Generics Market
The specialty injectable generic market is projected to register a CAGR of 10.2% during the forecast period (2022-2027).
Granisetron Market
The granisetron market is expected to register a CAGR of 6.2 % over the forecast period.
Global Argatroban Market
The argatroban market is expected to register a CAGR of 3.5% over the forecast period, 2022-2027.
Global Dyspnea Treatment Market
Dyspnea Treatment Market is expected to grow at a registered CAGR of 4.5% during the forecast period.
Other Reports Covering Hikma Pharmaceuticals
Pharmaceuticals
- Alexipharmic Drugs Market
- Antithrombotic Drugs Market
- Artificial Coma/Medically Induced Coma Market
- Bone Cancer Treatment Market
- Breast Cancer Therapy Market
- Capecitabine Market
- Global Antiemetic Drugs Market
- Global Argatroban Market
- Global Dyspnea Treatment Market
- Global General Anesthesia Drugs Market
- Global Heparin Market
- Global Opioids Market
- Global Oxytocin Market
- Global Pericarditis Drugs Market
- Global Specialty Injectable Generics Market
- Global Xerostomia (Dry Mouth Disease) Therapeutics Market
- Granisetron Market
- Hospital Infection Therapeutics Market
- Inhalation Anesthetics Market
- Morphine Market
- Myelodysplastic Syndrome (MDS) Treatment Market
- Saudi Arabia Active Pharmaceutical Ingredients (API) Market
